Authors

David Mulder

Associate

Read More

Christian Dekoninck

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Patrick Boháček

Associate

Read More

Agnieszka Sztoldman

Senior associate

Read More
Authors

David Mulder

Associate

Read More

Christian Dekoninck

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Patrick Boháček

Associate

Read More

Agnieszka Sztoldman

Senior associate

Read More

9 November 2020

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

  • Quick read

What is the role of patent law in emergency situations like the current coronavirus pandemic? And what exceptions to the law are there under such circumstances?

In the first article of our two-part series written for the European Intellectual Property Review, our international team consider these questions and more on both a broad, European level and from the perspective of six national jurisdictions.

Read the article here
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

ring binders on cabinet
Patents & innovation

Reloaded: How UK supplementary protection certificates will change from 1 January 2021

24 November 2020
Briefing

by Paul England, DPhil

Click here to find out more
uk-skyline
Patents & innovation

Plus ça change? How UK patents will be affected from 1 January 2021

18 November 2020
Briefing

by Paul England, DPhil

Click here to find out more
london-from-above
Patents & innovation

Why developments in global trade will highlight patent enforcement in the UK and Trans-Pacific countries

16 November 2020
Quick read

by multiple authors

Click here to find out more